Загрузка...
The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inf lammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid expansion of the bDMARDs market in Korea, reports of serious adverse events...
Сохранить в:
| Опубликовано в: : | Korean J Intern Med |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Association of Internal Medicine
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6960050/ https://ncbi.nlm.nih.gov/pubmed/31935319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2019.411 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|